Skip to Content

ENA 100 (Idhifa 100 mg)

Generic Name: enasidenib

Pill with imprint ENA 100 is Yellow, Capsule-shape and has been identified as Idhifa 100 mg. It is supplied by Celgene Corporation.

Idhifa is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics. Idhifa 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ENA 100

Idhifa 100 mg ENA 100

Idhifa

Generic Name
enasidenib
Imprint
ENA 100
Strength
100 mg
Color
Yellow
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
59572-0710
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, sodium lauryl sulfate, hypromellose acetate succinate 06081224 (3 mm2/s), silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, magnesium silicate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.